Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of ulixacaltamide in adults with essential tremor
CTR20244472Phase 3Active
- Sponsor
- Praxis Precision Medicines
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ulixacaltamide in essential tremor (ET), sponsored by Praxis Precision Medicines. Started Apr 2026; status: active.
02
Drugs
ulixacaltamide
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on CTR20244472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244472.